Susanne Schaffert's Net Worth

$246 Thousand

Estimate Recalculated Jul 17, 2024 11:33AM EST

Who is Susanne Schaffert?

Susanne Schaffert does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include INCYTE CORP, and Rubius Therapeutics, Inc..

SEC CIK

Susanne Schaffert's CIK is 0001938363

Past Insider Trading and Trends

2022 was Susanne Schaffert's most active year for acquiring shares with 3 total transactions. Susanne Schaffert's most active month to acquire stocks was the month of May. 2023 was Susanne Schaffert's most active year for disposing of shares, totalling 1 transactions. Susanne Schaffert's most active month to dispose stocks was the month of May. 2022 saw Susanne Schaffert paying a total of $0.00 for 58,376 shares, this is the most they've acquired in one year. In 2023 Susanne Schaffert cashed out on 488 shares for a total of $29,982.72, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INCYTE CORP (INCY) Snapshot price: $59.27

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+57.06%
2.08K
$59.94
-$45,074.88
5.72K
Jun 12
Form 4
+124.12%
2.02K
$61.44
-$29,982.72
3.64K
Jun 14
Form 4
∞
1.63K
—
—
1.63K
Oct 3
Form 3
—
0
—
—
0
No matching records found

Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.057

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 29
Form 3
—
0
—
—
0
No matching records found